Tech Company Financing Transactions
Medmain Funding Round
Medmain closed a $3.3 million financing round on 5/8/2025. Backers included One Capital, Niremia Collective and Plug and Play Ventures.
Transaction Overview
Company Name
Announced On
5/8/2025
Transaction Type
Venture Equity
Amount
$3,300,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to further enhance the development of its product, PidPort, invest in infrastructure for digitalization, strengthen its sales organization, apply for regulatory approval of its pathology AI, and build a foundation for international expansion.
Company Information
Company Status
Private & Independent
Industry
Software
Mailing Address
Undisclosed
Fukuoka, Undisclosed
Japan
Fukuoka, Undisclosed
Japan
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Medmain Inc. is a company to develop and provide "PidPort", a pathological AI analysis solution, with a corporate mission of "to create a world where medical services can be accessed with technology anywhere, anytime." "PidPort" is a product that enables the presentation of highly accurate and rapid analysis results by pathology AI developed by deep learning and the online pathological diagnosis such as remote pathological diagnosis.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Osamu Iizuka
Browse more venture capital transactions:
Prev: 5/8/2025: Juice venture capital transaction
Next: 5/8/2025: Una Software venture capital transaction
Share this article
Where The Data Comes From
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs